Viral Versus Non-Viral: What's the Better Vector?
Friday, May 31, 2024 05:00 PM - 06:00 PM
Room 205-207
Regulation & Policy
Roundtable
Organized by: ISCT 2024 Roundtable Committee
Supported by: ViroCell
Moderator(s)
Panelists
Debate pros and cons of different vector types in terms of:
Supported by: ViroCell
Moderator(s)
- Sandeep Soni, MD, CRISPR Therapeutics, United States
Panelists
- Farzin Farzaneh, PhD, FRCPatch, FRSB, ViroCell, United Kingdom
- Kevin Bosse, PhD, RAC, Nationwide Children's Hospital, United States
- Chris Barbosa, PhD, Acuitas Therapeutics, Canada
Debate pros and cons of different vector types in terms of:
- Technical barriers and innovation
- CMC
- Application
- Regulatory challenges
SPONSORED BY:
Sandeep Soni
Executive Director and Assoc. Prof. of Pediatrics
CRISPR Therapeutics and UCSF
Moderator
Executive Director and Assoc. Prof. of Pediatrics
CRISPR Therapeutics and UCSF
Moderator